X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs FRESENIUS KABI ONCO. - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS FRESENIUS KABI ONCO. J.B.CHEMICALS/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 15.0 22.1 67.6% View Chart
P/BV x 2.4 3.1 76.0% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
FRESENIUS KABI ONCO.
Mar-13
J.B.CHEMICALS/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs318176 180.7%   
Low Rs20079 254.1%   
Sales per share (Unadj.) Rs148.037.7 392.7%  
Earnings per share (Unadj.) Rs19.15.1 374.7%  
Cash flow per share (Unadj.) Rs23.96.7 356.2%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.942.5 303.1%  
Shares outstanding (eoy) m84.82158.23 53.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.4 51.8%   
Avg P/E ratio x13.625.0 54.3%  
P/CF ratio (eoy) x10.818.9 57.1%  
Price / Book Value ratio x2.03.0 67.1%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,95120,135 109.0%   
No. of employees `0002.71.2 237.3%   
Total wages/salary Rs m1,841703 261.8%   
Avg. sales/employee Rs Th4,590.95,176.2 88.7%   
Avg. wages/employee Rs Th673.4610.4 110.3%   
Avg. net profit/employee Rs Th592.1699.6 84.6%   
INCOME DATA
Net Sales Rs m12,5515,963 210.5%  
Other income Rs m54218 3,008.9%   
Total revenues Rs m13,0935,981 218.9%   
Gross profit Rs m2,0551,430 143.7%  
Depreciation Rs m412258 159.9%   
Interest Rs m96-26 -368.1%   
Profit before tax Rs m2,0881,216 171.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m469342 137.1%   
Profit after tax Rs m1,619806 200.9%  
Gross profit margin %16.424.0 68.3%  
Effective tax rate %22.528.1 79.8%   
Net profit margin %12.913.5 95.4%  
BALANCE SHEET DATA
Current assets Rs m7,7785,102 152.5%   
Current liabilities Rs m4,3582,385 182.7%   
Net working cap to sales %27.245.6 59.8%  
Current ratio x1.82.1 83.4%  
Inventory Days Days55150 36.4%  
Debtors Days Days80113 70.6%  
Net fixed assets Rs m5,7135,148 111.0%   
Share capital Rs m170158 107.2%   
"Free" reserves Rs m10,5476,556 160.9%   
Net worth Rs m10,9376,732 162.5%   
Long term debt Rs m0952 0.0%   
Total assets Rs m15,57410,388 149.9%  
Interest coverage x22.8-45.8 -49.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.6 140.4%   
Return on assets %11.07.5 146.6%  
Return on equity %14.812.0 123.6%  
Return on capital %20.014.6 136.7%  
Exports to sales %48.774.5 65.4%   
Imports to sales %7.124.8 28.6%   
Exports (fob) Rs m6,1154,441 137.7%   
Imports (cif) Rs m8891,477 60.2%   
Fx inflow Rs m6,1695,298 116.4%   
Fx outflow Rs m1,2851,772 72.5%   
Net fx Rs m4,8843,525 138.5%   
CASH FLOW
From Operations Rs m1,3971,274 109.6%  
From Investments Rs m-320-1,204 26.6%  
From Financial Activity Rs m-1,196-196 609.8%  
Net Cashflow Rs m-102-126 81.0%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 81.0 0.4%  
Indian inst/Mut Fund % 3.4 0.3 1,130.0%  
FIIs % 3.9 9.6 40.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 9.1 406.6%  
Shareholders   30,437 42,599 71.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 20, 2018 03:35 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - DISHMAN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS